Your browser is no longer supported. Please, upgrade your browser.
Settings
OPK Opko Health, Inc. daily Stock Chart
OPK [NASD]
Opko Health, Inc.
Index- P/E- EPS (ttm)-0.08 Insider Own6.70% Shs Outstand544.96M Perf Week2.40%
Market Cap3.49B Forward P/E- EPS next Y-0.03 Insider Trans9.69% Shs Float336.53M Perf Month-8.44%
Income-44.10M PEG- EPS next Q-0.05 Inst Own23.80% Short Float22.52% Perf Quarter-18.26%
Sales1.23B P/S2.84 EPS this Y26.00% Inst Trans-0.05% Short Ratio17.56 Perf Half Y-24.35%
Book/sh3.77 P/B1.70 EPS next Y85.00% ROA-1.60% Target Price13.90 Perf Year-35.68%
Cash/sh- P/C- EPS next 5Y12.00% ROE-2.10% 52W Range5.99 - 12.15 Perf YTD-31.18%
Dividend- P/FCF- EPS past 5Y-7.60% ROI-0.80% 52W High-47.33% Beta1.84
Dividend %- Quick Ratio1.60 Sales past 5Y112.80% Gross Margin49.60% 52W Low6.84% ATR0.23
Employees6041 Current Ratio1.70 Sales Q/Q1.80% Oper. Margin-7.10% RSI (14)49.71 Volatility3.58% 3.45%
OptionableYes Debt/Eq0.04 EPS Q/Q-153.00% Profit Margin-3.60% Rel Volume0.70 Prev Close6.44
ShortableYes LT Debt/Eq0.04 EarningsAug 07 AMC Payout- Avg Volume4.31M Price6.40
Recom1.80 SMA20-0.38% SMA50-1.49% SMA200-23.72% Volume3,035,488 Change-0.62%
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Jul-20-17 08:45AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : July 20, 2017 Capital Cube
Jul-18-17 04:05PM  Xenetic Biosciences Announces Adjournment of Annual Meeting of Stockholders until Wednesday, August 16, 2017 Business Wire
02:00PM  ETFs with exposure to OPKO Health, Inc. : July 18, 2017 Capital Cube
Jul-07-17 03:22PM  ETFs with exposure to OPKO Health, Inc. : July 7, 2017 Capital Cube
Jul-03-17 08:00AM  Today's Research Reports on Stocks to Watch: CEL-SCI Corporation and Opko Health Accesswire
Jun-29-17 06:42PM  Edited Transcript of OPK earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
Jun-26-17 04:37PM  ETFs with exposure to OPKO Health, Inc. : June 26, 2017 Capital Cube
04:26PM  How Things Look for Opko Health, Inc. in 3 Charts Motley Fool
08:35AM  Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction with Progestin Therapy for the Treatment of Endometrial Cancer Business Wire
Jun-22-17 08:30AM  OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD GlobeNewswire -5.51%
08:14AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : June 22, 2017 Capital Cube
Jun-16-17 04:09PM  ETFs with exposure to OPKO Health, Inc. : June 16, 2017 Capital Cube
Jun-15-17 09:12AM  OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults GlobeNewswire
Jun-14-17 09:27AM  OPKO Health, Inc. :OPK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-13-17 08:00AM  Today's Research Reports on Stocks to Watch: Exelixis and Opko Health Accesswire
Jun-07-17 08:00AM  OPKOS GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing GlobeNewswire
Jun-05-17 11:17AM  OPKO Health Provides Commercial Update for RAYALDEE GlobeNewswire -6.26%
10:55AM  Here's Why Opko Health Inc. Slipped 18.8% in May Motley Fool
Jun-01-17 04:15PM  James J. Martin Appointed as Chief Financial Officer of Cocrystal Pharma, Inc. Marketwired
May-25-17 08:43AM  Is the Options Market Predicting a Spike in Opko Health (OPK) Stock? Zacks
08:32AM  3 Value Stocks You Might Not Have Thought Of Motley Fool
May-22-17 07:00AM  Xenetic Biosciences Receives Program Update from Partner Shires Phase 1/2 Study Evaluating SHP656 in Development as a Long-acting Treatment for Hemophilia A Business Wire
07:00AM  MabVax Therapeutics Announces the Closing of its $4.1 Million Public Offering PR Newswire
May-18-17 08:00AM  OPKO Healths 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting GlobeNewswire
May-16-17 07:00AM  Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update Business Wire
May-15-17 08:00AM  OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting GlobeNewswire -5.42%
May-10-17 12:56AM  Edited Transcript of OPK earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents -7.04%
May-09-17 05:16PM  OPKO Health reports 1Q loss Associated Press
04:32PM  CORRECTION -- OPKO Health Inc. GlobeNewswire
04:10PM  OPKO Health Reports 2016 Financial and Operating Results GlobeNewswire
03:05PM  Investor Network: OPKO Health, Inc. to Host Earnings Call Accesswire
08:35AM  Xenetic Biosciences to Host 2017 First Quarter Update Conference Call Business Wire
May-08-17 05:03PM  ETFs with exposure to OPKO Health, Inc. : May 8, 2017 Capital Cube
08:00AM  OPKO Health to Announce 2017 First Quarter Financial Results on May 9, 2017 GlobeNewswire
May-01-17 08:30AM  Xenetic Biosciences Presents Case Study of PolyXen Platform Technology at the 13th Annual Protein Engineering Summit (PEGS) Boston Business Wire
Apr-27-17 04:12PM  ETFs with exposure to OPKO Health, Inc. : April 27, 2017 Capital Cube
Apr-24-17 04:15PM  Cocrystal Pharma Receives Investment Through Private Placement Marketwired
Apr-20-17 07:35AM  Xenetic Biosciences PolyXen Platform Technology Accepted for Poster Presentation at the 13th Annual Protein Engineering Summit (PEGS) Boston Business Wire
Apr-19-17 09:21AM  3 Beaten-Up Healthcare Stocks: Are They Bargains? Motley Fool +5.77%
Apr-17-17 01:02PM  ETFs with exposure to OPKO Health, Inc. : April 17, 2017 Capital Cube
Apr-05-17 05:14PM  ETFs with exposure to OPKO Health, Inc. : April 5, 2017 Capital Cube
Apr-04-17 07:05AM  Xenetic Biosciences Expands Executive Management Team with Appointment of James F. Parslow, MBA, CPA as Chief Financial Officer Business Wire
Mar-30-17 06:20PM  OPKO Health, Inc. :OPK-US: Earnings Analysis: 2016 By the Numbers : March 30, 2017 Capital Cube
Mar-29-17 08:11AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : March 29, 2017 Capital Cube
Mar-28-17 06:30AM  ChromaDex Appoints Steven D. Rubin, J.D., to its Board of Directors GlobeNewswire
Mar-25-17 12:03PM  3 Stocks That Could Double Your Money Motley Fool
Mar-23-17 04:33PM  OPKO HEALTH, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
Mar-22-17 10:48AM  Opko Gets Orphan Status for Genetic Disorder Drug Investopedia
08:00AM  OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder GlobeNewswire
Mar-16-17 04:33PM  Benzinga's Option Alert Recap From March 16
Mar-14-17 08:30AM  OPKO Health's GeneDx to have Significant Presence at ACMG 2017 GlobeNewswire
08:00AM  OPKO Health to Participate in the Barclays Global Healthcare Conference GlobeNewswire
Mar-11-17 12:04PM  Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc. at Motley Fool
Mar-09-17 09:30AM  Biotech's Rally in 2017 Stumbles on Pricing Concerns: Today's Research Reports on Opko Health and Cerus Accesswire
Mar-08-17 01:04PM  OPKO HEALTH, INC. Financials
10:56AM  OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest
08:00AM  OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder GlobeNewswire
Mar-07-17 06:18PM  Opko Health subsidiary launches prenatal testing tool at bizjournals.com
11:21AM  OPKO Health, Inc. :OPK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
08:00AM  OPKO Subsidiary GenPath Womens Health Announces the Availability of ClariTest GlobeNewswire
Mar-06-17 01:18PM  Weekly CEO Buys Highlights
12:34PM  OPKO Health, Inc. :OPK-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017
Mar-03-17 08:00AM  OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development GlobeNewswire
Mar-02-17 04:47PM  Here's Why Opko Health Inc. Stock Lost Some More Ground Today at Motley Fool -11.29%
04:40PM  Why Endeavour Silver, Opko Health, and Barnes & Noble Slumped Today at Motley Fool
12:20PM  Thursdays Top Biopharma Movers
Mar-01-17 09:52PM  Edited Transcript of OPK earnings conference call or presentation 1-Mar-17 9:30pm GMT
07:13PM  Cramer's lightning round: The stock 'kicking butt' in cybersecurity at CNBC
05:43PM  OPKO Health reports 4Q loss
04:16PM  OPKO HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financ
04:13PM  OPKO Health Reports 2016 Financial and Operating Results GlobeNewswire
07:07AM  Q4 2016 OPKO Health Inc Earnings Release - After Market Close
Feb-28-17 09:30AM  OPKO Healths GeneDx Announces Participation in Illuminas iHope Program on International Rare Disease Day GlobeNewswire
Feb-27-17 04:15PM  OPKO Health to Announce 2016 Fourth Quarter Financial Results on March 1, 2017 GlobeNewswire
Feb-21-17 05:18PM  OPKO Health to Participate at Upcoming Healthcare Investment Conferences GlobeNewswire
Feb-17-17 09:30AM  Biotech Industry Positioned for a Potential Breakout in 2017: Today's Reports on Array Biopharma and Opko Health Accesswire
Feb-10-17 04:29PM  OPKO HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers
04:20PM  Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017 at Motley Fool
Feb-08-17 08:00AM  OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis GlobeNewswire
Feb-07-17 08:00AM  OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer GlobeNewswire
Feb-02-17 01:30PM  Opko Health subsidiary dives into human genome research at bizjournals.com
Feb-01-17 12:21PM  5 Stocks Insiders Love Right Now
08:30AM  OPKOS GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute GlobeNewswire
Jan-31-17 10:30AM  OPKO Health CEO on Trump Administration, Biotech Outlook
Jan-30-17 03:26PM  OPKO Health CEO Frost on 4Kscore Test for Prostate Cancer
Jan-27-17 03:51PM  Billionaire's $100M gift to SoFla university funneled to STEM efforts at bizjournals.com
Jan-24-17 04:24PM  OPKO HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-19-17 10:58PM  Better Buy: Opko Health, Inc. vs. Qiagen at Motley Fool
Jan-16-17 01:24PM  Opko Health Eyes Better 2017 After Disastrous 2016 at Investopedia
Jan-13-17 03:24PM  It's Full Speed Ahead for Opko Health After Pipeline Stumble at Motley Fool
Jan-10-17 04:27PM  OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
03:41PM  How a Bust Caused Opko Health Shares to Tumble in 2016 at Motley Fool
01:20PM  Opko Health investee company launches into new partnership at bizjournals.com
08:30AM  OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics GlobeNewswire
Jan-09-17 01:31PM  OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA GlobeNewswire
10:55AM  Weekly CEO Buys Highlights
Jan-07-17 12:12PM  Top Insider Buys Highlight for Week of Jan. 6
Jan-04-17 03:56PM  What's Next for Opko Health After Its Recent Clinical Setback? at Motley Fool
08:30AM  OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference GlobeNewswire
02:18AM  OPKO Health, Inc. breached its 50 day moving average in a Bearish Manner : OPK-US : January 4, 2017
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3-4 chronic kidney disease patients with vitamin D deficiency; and VARUBI for chemotherapy-induced nausea and vomiting. This segment is also developing TT401, which is in Phase II clinical trials for type 2 diabetes and obesity; TT701, an androgen receptor modulator that is in Phase II clinical trials for androgen deficiency indications; and hGH-CTP, a growth hormone injection that is in Phase III clinical trials. In addition, it engages in developing and commercializing hGH-CTP, a recombinant human growth hormone product that is in Phase III; developing Factor VIIa drug for hemophilia that is in Phase IIa, an NK-1 compound, and drugs for treating asthma and chronic obstructive pulmonary disease; developing and producing specialty active pharmaceutical ingredients; and discovery of drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, this segment engages in the development, manufacture, and sale of pharmaceutical, nutraceutical, and veterinary products; and markets and distributes pharmaceutical and natural products. Additionally, OPKO Health, Inc. operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanJul 24Buy6.4245,000289,050163,757,343Jul 25 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 20Buy6.465,40034,872163,712,343Jul 21 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 17Buy6.041,80010,871163,706,943Jul 18 07:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 14Buy6.1612,60077,564163,705,143Jul 17 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 12Buy6.123,60022,050163,692,543Jul 13 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 10Buy6.1950,000309,570163,688,943Jul 11 06:38 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 06Buy6.2925,000157,141163,638,943Jul 07 06:26 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 03Buy6.4460,800391,396163,613,943Jul 05 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 30Buy6.583,60023,700163,553,143Jul 03 08:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 28Buy6.871,80012,366163,549,543Jun 29 06:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 27Buy6.7721,800147,541163,547,743Jun 28 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 26Buy6.971,80012,543163,525,943Jun 27 07:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 22Buy6.72131,000880,268163,524,143Jun 23 06:31 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 15Buy6.43200,0001,285,692163,393,143Jun 16 06:17 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 13Buy6.517,20046,901163,193,143Jun 14 06:33 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 12Buy6.371,80011,458163,185,943Jun 13 06:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 09Buy6.3925,000159,643163,184,143Jun 12 06:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 07Buy6.2755,600348,785163,159,143Jun 08 07:39 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 06Buy6.3030,000189,147163,103,543Jun 07 07:26 AM
LERNER RICHARD ADirectorJun 05Buy6.3110,00063,135166,172Jun 06 07:16 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 05Buy6.3155,000347,135163,073,543Jun 06 07:17 AM
PFENNIGER RICHARD C JRDirectorJun 02Option Exercise3.4320,00068,600170,000Jun 05 09:49 AM
PAGANELLI JOHN ADirectorJun 01Buy6.175,00030,8409,175Jun 02 11:36 AM
Rubin Steven DExecutive VP-AdministrationMay 31Buy6.102,00012,2005,685,915Jun 01 09:27 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 31Buy6.11207,7001,269,461163,018,543Jun 01 06:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 30Buy6.2818,600116,773162,810,843May 31 06:48 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 26Buy6.3164,600407,432162,792,243May 30 07:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 25Buy6.3826,000165,786162,727,643May 26 07:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 24Buy6.4242,200270,959162,701,643May 25 06:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 22Buy6.43120,000772,174162,659,443May 23 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 19Buy6.609,20060,685162,539,443May 22 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 18Buy6.5920,000131,808162,530,243May 19 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 17Buy6.5470,800463,256162,510,243May 18 07:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 16Buy6.6127,800183,634162,439,443May 17 06:45 AM
HSIAO JANE PH DVice Chairman & CTOMay 11Buy6.9320,000138,50024,773,133May 12 10:53 AM
Rubin Steven DExecutive VP-AdministrationMay 11Buy6.912,00013,8145,683,915May 11 02:17 PM
FROST PHILLIP MD ET ALCEO & ChairmanMay 10Buy6.961,125,0007,829,775162,411,643May 11 06:41 AM
HSIAO JANE PH DVice Chairman & CTOMay 10Buy6.9740,000278,70524,753,133May 11 06:50 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 08Buy7.22100,000722,248161,286,643May 09 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 05Buy7.5210,00075,234161,186,643May 08 06:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 04Buy7.5111,80088,592161,176,643May 05 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 03Buy7.5311,00082,784161,164,843May 04 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 02Buy7.5815,000113,760161,153,843May 02 06:56 PM
FROST PHILLIP MD ET ALCEO & ChairmanMay 01Buy7.684,70036,104161,138,843May 02 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 28Buy7.789,00070,010161,134,143May 01 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 27Buy7.8122,500175,787161,125,143Apr 28 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 26Buy7.845,00039,196161,102,643Apr 27 07:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 21Buy7.4819,000142,197161,097,643Apr 24 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 19Buy7.4915,000112,291161,078,643Apr 20 07:27 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 18Buy7.2627,800201,790161,063,643Apr 19 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 17Buy7.4813,600101,676161,035,843Apr 18 07:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 13Buy7.5830,800233,400161,022,243Apr 14 07:45 AM
Rubin Steven DExecutive VP-AdministrationApr 12Option Exercise2.36265,000625,4005,840,251Apr 13 04:25 PM
FROST PHILLIP MD ET ALCEO & ChairmanApr 11Buy7.4918,000134,909160,991,443Apr 12 06:12 AM
Yu Alice Lin-TsingDirectorApr 10Option Exercise4.7220,00094,400100,000Apr 11 04:14 PM
FROST PHILLIP MD ET ALCEO & ChairmanApr 10Buy7.6033,000250,842160,973,443Apr 11 07:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 07Buy7.5828,000212,220160,940,443Apr 10 08:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 06Buy7.5828,600216,881160,912,443Apr 07 08:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 05Buy7.6944,500342,042160,883,843Apr 06 07:31 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 04Buy7.697,40056,943160,839,343Apr 05 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 03Buy7.8221,600168,908160,831,943Apr 04 07:36 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 31Buy8.001,80014,400160,810,343Apr 03 07:34 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 30Buy8.0210,60085,043160,808,543Mar 31 07:40 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 29Buy8.149,20074,847160,797,943Mar 30 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 28Buy8.033,60028,895160,788,743Mar 29 08:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 24Buy7.753,60027,917160,785,143Mar 27 06:26 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 23Buy7.7112,20094,024160,781,543Mar 24 07:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 21Buy7.855,80045,531160,769,343Mar 22 07:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 20Buy7.9911,00087,924160,763,543Mar 21 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 17Buy8.199,00073,710160,752,543Mar 20 07:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 15Buy8.031,80014,454160,743,543Mar 16 07:10 AM
Logal AdamSr. Vice President, CFOMar 14Sale8.07112,975911,674161,293Mar 15 06:31 PM
Logal AdamSr. Vice President, CFOMar 13Option Exercise1.07264,207282,956309,996Mar 15 06:31 PM
LERNER RICHARD ADirectorMar 13Option Exercise2.0520,00041,00050,000Mar 15 06:30 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 10Buy7.971,80014,345160,741,743Mar 13 07:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 09Buy7.843,60028,209160,739,943Mar 10 07:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 08Buy7.921,80014,256160,736,343Mar 09 07:07 AM
PAGANELLI JOHN ADirectorMar 06Option Exercise3.4320,00068,600359,355Mar 07 05:08 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 03Buy7.438,60063,895160,734,543Mar 06 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 02Buy7.5394,800713,787160,725,943Mar 03 08:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 24Buy8.453,60030,436160,631,143Feb 27 07:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 23Buy8.391,80015,102160,627,543Feb 24 06:11 AM
PAGANELLI JOHN ADirectorFeb 22Option Exercise2.0520,00041,000344,208Feb 28 06:27 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 22Buy8.541,80015,371160,625,743Feb 23 07:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 21Buy8.803,60031,680160,623,943Feb 22 07:21 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 17Buy8.801,80015,836160,620,343Feb 21 06:36 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 16Buy8.651,80015,570160,618,543Feb 17 07:33 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 15Buy8.461,80015,228160,616,743Feb 16 06:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 14Buy8.411,80015,138160,614,943Feb 15 07:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 13Buy8.361,80015,046160,613,143Feb 14 07:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 10Buy8.141,80014,656160,611,343Feb 13 07:27 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 09Buy8.0710,00080,696160,609,543Feb 10 07:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 08Buy8.1315,600126,891160,599,543Feb 09 07:49 AM
Rubin Steven DExecutive VP-AdministrationFeb 08Buy8.112,00016,2145,575,251Feb 09 07:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 07Buy8.275,40044,671160,583,943Feb 08 07:36 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 06Buy8.3220,600171,435160,578,543Feb 07 10:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 02Buy8.536,00051,156160,557,943Feb 03 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 01Buy8.599,00077,341160,551,943Feb 02 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 31Buy8.6012,000103,179160,542,943Feb 01 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 30Buy8.4910,00084,860160,530,943Jan 31 06:03 AM